Anesthesia And Respiratory Devices Market (2026 - 2033)

Anesthesia & Respiratory Devices Market Summary

The global anesthesia and respiratory devices market size was valued at USD 58.3 billion in 2025 and is projected to grow from USD 60.5 billion in 2026 to USD 91.5 billion by 2033, at a CAGR of 6.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of over 30.0% in 2025. The industry is driven by an increased incidence of respiratory disorders such as Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD), fast urbanization, an increase in surgical operations, pollution levels, a geriatric population, and a smoking population.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

According to the Australian Institute of Health and Welfare (AIHW), in February 2026, chronic obstructive pulmonary disease (COPD) accounted for 3.7% of the total disease burden in Australia in 2024. Furthermore, according to the CDC/NCHS → National Health Interview Survey (NHIS), 2019–2024, nearly 4.2% of U.S. adults reported having been diagnosed with COPD, emphysema, or chronic bronchitis in 2024, underscoring the continued demand for respiratory monitoring and treatment devices.

Innovation and the development of novel products equipped with advanced technological features are critical to the growth of this industry. Companies engaged in the manufacturing and marketing of such medical devices have been developing and designing devices that provide convenience and help patients with various needs. For instance, in March 2026, AeroDel Technology Innovations signed an exclusive licensing agreement with Zydus Lifesciences and introduced Aerolife Mini, a foldable, always-attached pMDI enhancer. Such developments highlight the role of innovation in shaping the industry's future course.

Recent Product Launches and Developments

Market Concentration & Characteristics

The degree of innovation in the industry is high. Continuous technological advancements in anesthesia and respiratory devices are leading to portable ventilators, AI-enabled monitoring systems, smart inhalers, integrated workstations, and cloud-based patient monitoring. Manufacturers are prioritizing automation, predictive analytics, real-time clinical decision support, and interoperability with hospital information systems to improve treatment precision, patient safety, and workflow efficiency in critical care, surgical, and home healthcare environments.

The M&A activities, such as mergers, acquisitions, and partnerships, enable companies to expand geographically, financially, and technologically. In June 2026, Withings announced the acquisition of Biosency, a Rennes-based company engaged in the monitoring of patients with respiratory insufficiency. Backed by Withings’ expertise, Biosency is likely to focus on the scaling and commercialization of its solution.

The impact of regulations is moderate to high in the industry. The industry involves several digital technologies, including AI and ML. It is regulated by different bodies in different countries. The U.S. FDA regulates anesthesia and respiratory devices, along with other medical devices, in the U.S. The industry players might face severe challenges if they fail to abide by the regulations. For instance, in April 2024, a federal court mandated that Philips RS North America LLC (Philips Respironics) halt the manufacturing and distribution of most respiratory and sleep devices at three Pennsylvania facilities. This order requires the company to implement specific safety measures and ensure compliance with the Federal Food, Drug, and Cosmetic Act (FDCA).

Geographical expansion is a key growth strategy for companies in the anesthesia and respiratory devices market, allowing them to strengthen their presence in emerging and underserved healthcare markets. Manufacturers are broadening distribution networks, forming local partnerships, and enhancing regional manufacturing and service capabilities to meet rising demand for respiratory care solutions. These efforts improve access to advanced technologies, support healthcare infrastructure development, and help companies meet regional regulatory requirements while responding to the increasing prevalence of respiratory diseases in developing regions.

Analyst Perspective

The anesthesia and respiratory devices market is expected to grow steadily due to rising chronic respiratory diseases, surgical procedures, an aging population, and better healthcare infrastructure. Demand is increasing for advanced respiratory support, intelligent ventilation, AI-enabled monitoring, and integrated anesthesia workstations, driven by healthcare providers' focus on efficiency, safety, and treatment outcomes. The expansion of home-based respiratory care and remote patient monitoring is creating new opportunities for oxygen therapy, positive airway pressure, and other connected respiratory devices. APAC is projected to register the fastest growth, supported by expanding healthcare expenditure, infrastructure development, rising surgical volumes, and improved access to advanced medical technologies. Overall, product innovation, hospital modernization, and growing adoption of connected, patient-centric care solutions are expected to support overall market growth.

Product Insights

Respiratory devices accounted for the largest share of approximately 34.0% in 2025, driven by the rising prevalence of respiratory diseases, the availability of advanced respiratory devices, the growing number of surgeries performed, and rising healthcare expenditure. These devices manage and treat conditions including fibrosis, asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome. For instance, in March 2025, Getinge launched Neural Pressure Support (NPS) for its Servo-u ventilator system. This update introduced new ventilation modes that synchronize respiratory support with patients' neural breathing signals, enhancing efficiency and patient comfort in intensive care.

The anesthesia devices segment is experiencing significant growth, driven by the increasing number of surgical procedures, both elective and emergency. This rise has increased demand for advanced anesthesia workstations and delivery systems in hospitals and ambulatory surgical centers. In addition, the prevalence of chronic diseases such as cardiovascular disorders, cancer, and orthopedic conditions, particularly among the aging population, is contributing to a greater volume of surgeries, which in turn boosts the adoption of anesthesia devices.

Regional Insights

North America anesthesia and respiratory devices market accounted for the largest revenue share of over 30.0% in 2025. The increasing geriatric population in the U.S. is driving a rise in surgeries, boosting market growth. According to the U.S. Census Bureau report published in June 2026, over 61.2 million adults aged 65 and above lived in the U.S., marking nearly 3.1% growth from 2023. Such statistics highlight the growth potential of this industry and opportunities associated with these devices in the region.

To learn more about this report, Download Free Sample Report

U.S. Anesthesia and Respiratory Devices Market Trends

The anesthesia and respiratory devices market in the U.S. is driven by favorable reimbursement policies that support the adoption of these devices. A significant development occurred in March 2024, when a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to improve access to supplementary oxygen for Medicare beneficiaries. This legislation is expected to boost the adoption of oxygen concentrators nationwide. In addition, rising healthcare spending in the U.S. is increasing the demand for effective diagnosis and treatment of respiratory diseases, further driving the market for oxygen concentrators.

Europe Anesthesia and Respiratory Devices Market Trends

The anesthesia and respiratory devices market in Europe is projected to experience significant growth during the forecast period. The region's robust healthcare infrastructure and commitment to innovation drive the adoption of advanced mechanical ventilators. In addition, the aging population in Europe is leading to a rise in respiratory illnesses and chronic obstructive pulmonary disease (COPD), increasing the demand for ventilator support. For instance, Eurostat projects that by 2050, Europe is expected to have nearly half a million centenarians, with the median age expected to rise by 4.5 years to 48.2 years.

The UK anesthesia and respiratory devices market had a substantial share in 2025. The growth is attributed to the active participation of market players and other organizations in developing cost-effective respiratory devices, among other factors. For instance, in May 2025, AstraZeneca announced that the UK had approved Trixeo Aerosphere as the world's first inhaled respiratory medicine with a next-generation propellant with near-zero global warming potential. The inhaler offers the same efficacy and safety for treating chronic obstructive pulmonary disease (COPD) while significantly reducing environmental impact, supporting the adoption of sustainable respiratory therapies in the UK.

The anesthesia and respiratory devices market in France is growing as market players expand their product portfolios and improve access to advanced technologies. Increased healthcare investments, greater use of minimally invasive procedures, a higher prevalence of chronic respiratory diseases, and the adoption of digital health solutions are key drivers. Supportive government policies, ongoing technological advancements, and the presence of leading manufacturers also contribute to market expansion.

Asia Pacific Anesthesia and Respiratory Devices Market Trends

The anesthesia and respiratory devices market in the Asia Pacific is expected to exhibit the highest growth from 2026 to 2033, several key factors, including rising healthcare awareness, increasing prevalence of respiratory diseases, technological advancements, and supportive government initiatives & market interventions.

The region is also witnessing growing investments in advanced respiratory care technologies and improved access to innovative treatment solutions, supporting the adoption of next-generation respiratory devices. For instance, in January 2025, Beyond Air announced that its LungFit PH system received market authorization from Australia's Therapeutic Goods Administration (TGA). This nitric oxide delivery system, designed for ventilated patients, is set to be commercialized in Australia through Getz Healthcare, its Asia Pacific partner, further expanding access to advanced respiratory care across the region.

Japan anesthesia and respiratory devices market held a significant share in the APAC in 2025. Nebulizers, oxygen concentrators, ventilators, and other respiratory devices are experiencing high demand due to the rising prevalence of respiratory diseases. Consequently, the market for anesthesia and respiratory devices in Japan is expected to grow as the incidence of respiratory conditions continues to rise.

The anesthesia and respiratory devices market in India is growing due to increased healthcare investments, a higher prevalence of respiratory diseases, and rising demand for advanced critical care and surgical technologies. Government efforts to improve healthcare access, expand hospital networks, and boost healthcare spending, along with the adoption of advanced devices, are supporting this growth. The expansion of domestic manufacturing and the presence of global medical device companies are also driving market development.

Key Anesthesia And Respiratory Devices Market Company Insights

Key players operating in the anesthesia and respiratory devices market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Key Anesthesia And Respiratory Devices Companies

The following key companies have been profiled for this study on the anesthesia and respiratory devices market:

• Drägerwerk AG & Co. KGaA

• Fisher & Paykel Healthcare Limited.

• GE HealthCare

• Getinge

• Koninklijke Philips N.V.

• Masimo Corporation

• Medtronic

• Mindray Medical India Pvt. Ltd

• ResMed Inc.

• Smiths Group plc

• Teleflex Incorporated

Recent Developments

• In September 2025, Philips and Getinge formed a commercial alliance to deliver an integrated anesthesia solution that combines Getinge's Flow Family anesthesia delivery systems with Philips' IntelliVue patient monitoring technology. Powered by IntelliBridge EC10, this solution enables seamless data exchange, streamlines clinical workflows, and enhances perioperative care in operating rooms.

• In October 2025, GE HealthCare introduced the Carestation 850, a next-generation anesthesia delivery system. It offers advanced ventilation, customizable applications, improved data visualization, and sustainability-focused features. These enhancements help anesthesia care teams increase workflow efficiency and deliver better patient care in diverse surgical settings.

• In May 2024, Masimo partnered with Medable Inc. to integrate medical-grade wearable devices into clinical research. Medable incorporated Masimo’s MightySat Rx pulse oximeter in its evidence-generation platform for eight large-scale pharmaceutical clinical trials. These trials, involving over 3,000 patients across 25 countries, are focused on two oncology indications: breast and lung cancer.

• In April 2024, Royal Philips initiated the establishment of an additional R&D center within its Healthcare Innovation Center (HIC) in Maharashtra, underscoring India's increasing significance in global healthcare innovation. This new facility, set to be functional within two years, which is likely to house R&D units dedicated to Sleep & Respiratory Care, Precision Diagnosis, Image Guided Therapy, and Monitoring.

Global Anesthesia And Respiratory Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global anesthesia and respiratory devices market report based on product, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Respiratory Devices
    • Respiratory Equipment
      • Humidifiers
        • Heat Humidifiers
        • Heated Wire Breathing Circuits
        • Heat Exchangers
        • Pass Over Humidifiers
      • Nebulizers
        • Pneumatic Nebulizers
        • Mesh Nebulizers
        • Ultrasonic Nebulizers
      • Oxygen Concentrator
        • Fixed Oxygen Concentrators
        • Portable Oxygen Concentrators
      • Positive Airway Pressure Devices
        • Bilevel & automatic positive airway pressure devices
        • Continuous positive airway pressure devices
      • Reusable Resuscitators
      • Ventilators
        • Adult Ventilators
        • Neonatal Ventilators
      • Respiratory Inhalers
        • Dry Powdered Inhalers
        • Metered Dose Inhaler
    • Respiratory Disposables
      • Disposable Oxygen Masks
      • Resuscitators
      • Tracheostomy Tubes
      • Oxygen Cannula
    • Respiratory Measurement Devices
      • Pulse Oximetry systems
      • Capnographs
      • Spirometers
      • Peak Flowmeters
  • Anesthesia Devices
    • Anesthesia Machines
      • Anesthesia Workstation
      • Anesthesia delivery machines
        • Portable
        • Standalone
      • Anesthesia Ventilators
      • Anesthesia Monitors
    • Anesthesia Disposables
      • Anesthesia Masks
      • Anesthesia Accessories
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait